deltatrials
Completed PHASE3 NCT00031785

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

A Phase III, Double-Blind, Randomized Study of the Effect of Megestrol Acetate on Weight and Health Related Quality of Life in Lung Cancer Patients Receiving Thoracic Radiation Therapy

Sponsor: National Cancer Institute (NCI)

Conditions Anorexia Cachexia Lung Cancer
Interventions megestrol acetate radiation therapy
Updated 8 times since 2017 Last updated: Sep 7, 2021 Started: Sep 1, 2000 Primary completion: Sep 11, 2002 Completion: Sep 11, 2002

This PHASE3 trial investigates Anorexia and Cachexia and is currently completed. National Cancer Institute (NCI) leads this study, which shows 8 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Oct 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Oct 2021 [monthly]

    Completed PHASE3

  5. Sep 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 3 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Completed PHASE3

  2. May 2017 — Jun 2018 [monthly]

    Completed PHASE3

  3. Jan 2017 — May 2017 [monthly]

    Completed PHASE3

    First recorded

Sep 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Wake Forest University Health Sciences
Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Winston-Salem, United States